An independent bench comparison of two bioresorbable drug-eluting coronary scaffolds (Absorb and DESolve) with a durable metallic drug-eluting stent (ML8/Xpedition)

EuroIntervention

Volumn 11, Issue 1, 2015, Pages 60-67

  Ormiston, John A ^a,b,c   Webber, Bruce ^a   Ubod, Ben ^a   Darremont, Olivier ^d   Webster, Mark W I ^a,b,c  

^a Mercy Angiography   (New Zealand)

^b AUCKLAND CITY HOSPITAL   (New Zealand)

^c UNIVERSITY OF AUCKLAND   (New Zealand)

^d CLINIQUE SAINT AUGUSTIN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BALLOON DILATATION; BIORESORBABLE SCAFFOLD; COMPARATIVE STUDY; CONTROLLED STUDY; DEVICE SAFETY; EVEROLIMUS ELUTING CORONARY STENT; MATERIALS TESTING; MECHANICS; PHYSICAL PARAMETERS; RECOIL; STENT FRACTURE; STRUT THICKNESS; DEVICE FAILURE ANALYSIS; DEVICES; DRUG ELUTING STENT; HEART CATHETER; MECHANICAL STRESS; PRESSURE; PROSTHESIS DESIGN; PROSTHESIS FAILURE; TIME FACTOR; TRANSLUMINAL CORONARY ANGIOPLASTY;

BIOCOMPATIBLE COATED MATERIAL; CARDIOVASCULAR AGENT; METAL;

ANGIOPLASTY, BALLOON, CORONARY; CARDIAC CATHETERS; CARDIOVASCULAR AGENTS; COATED MATERIALS, BIOCOMPATIBLE; DRUG-ELUTING STENTS; EQUIPMENT FAILURE ANALYSIS; MATERIALS TESTING; METALS; PRESSURE; PROSTHESIS DESIGN; PROSTHESIS FAILURE; STRESS, MECHANICAL; TIME FACTORS;

EID: 85001560593     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJY15M02_03     Document Type: Article

References (18)

1. Sarno G, Lagerqvist B, Frobert O, Nilsson T, Olivecrona G, Omerovic E, Saleh N, Venetzanos D, James S. Lower risk of stent thrombosis and restenosis with unrestricted access of 'new-generation' drug-eluting stents: a report from the nationwide Swedish Coronary Angiography and Angioplasty Registry (SCAAR). Eur Heart J. 2012;33:606-13.
2. Brugaletta S, Radu MD, Garcia-Garcia HM, Heo JH, Farooq V, Girasis C, van Geuns RJ, Thuesen L, McClean D, Chevalier B, Windecker S, Koolen J, Rapoza R, Miquel-Hebert K, Ormiston J, Serruys PW. Circumferential evaluation of the neointima by optical coherence tomography after ABSORB bioresorbable vascular scaffold implantation: can the scaffold cap the plaque? Atherosclerosis. 2012;221:106-12.
3. Serruys PW, Chevalier B, Dudek D, Cequier A, Carrie D, Iniguiez A, Dominici M, van der Schaaf RJ, Haude M, Wasungu L, Veldhof S, Peng L, Staehr P, Grundeken MJ, Ishibashi Y, Garcia-Garcia HM, Onuma Y. A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes of a randomised controlled trial. Lancet. 2015;385:43-54.
4. Ormiston JA, Serruys PW. Bioresorbable coronary stents. Circ Cardiovasc Interv. 2009;2:255-60.
5. Ormiston JA, Webster M, Onuma Y, Serruys PW. Bioresorbable coronary scaffolds, in Price MJ. Coronary Stenting: A Companion to Topol's Textbook of Interventional Cardiology. Philadelphia, PA, USA: Elsevier; 2014.
6. Ormiston JA, De Vroey F, Serruys PW, Webster M. Bioresorbable polymeric vascular scaffolds: a cautionary tale. Circ Cardiovasc Interv. 2011;4:535-8.
7. Louvard Y, Thomas M, Dzavik V, Hildick-Smith D, Galassi AR, Pan M, Burzotta F, Zelizko M, Dudek D, Ludman P, Sheiban I, Lassen JF, Darremont O, Kastrati A, Ludwig J, Iakovou I, Brunel P, Lansky A, Meerkin D, Legrand V, Medina A, Lefèvre T. Classification of coronary artery bifurcation lesions and treatments: time for a consensus! Catheter Cardiovasc Interv. 2008;71:175-83.
8. Ormiston JA, Webber B, Ubod B, Webster MW, White J. Absorb everolimus-eluting bioresorbable scaffolds in coronary bifurcations: a bench study of deployment, side branch dilatation and post-dilatation strategies. EuroIntervention. 2015;10:1169-77.
9. Kuntz RE, Safian RD, Carrozza JP, Fischman RF, Mansour M, Baim DS. The importance of acute lumen diameter in determining restenosis after coronary atherectomy or stenting. Circulation. 1992;86:1827-35.
10. Ormiston JA, Serruys PW, Onuma Y, van Geuns RJ, de Bruyne B, Dudek D, Thuesen L, Smits PC, Chevalier B, McClean D, Koolen J, Windecker S, Whitbourn R, Meredith I, Dorange C, Veldhof S, Herbert KM, Rapoza R, Garcia-Garcia HM. First serial assessment at 6 months and 2 years of the second generation of absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study. Circ Cardiovasc Interv. 2012;5:620-32.
11. Capodanno D, Gori T, Nef H, Latib A, Mahilli J, Lesiak M, Caramanno G, Naber C, Di Mario C, Colombo A, Caprazano P, Wiebe J, Araszkiewicz A, Geraci S, Pyxaras S, Mattesini A, Naganuma T, Munzel T, Tamburino C. Percutaneous coronary ntervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry. EuroIntervention. 2015;10:1144-53.
12. th European Bifurcation Club meeting. EuroIntervention. 2010;6:34-8.
13. Lassen JF, Holm NR, Stankovic G, Lefevre T, Chieffo A, Hildick-Smith D, Pan M, Darremont O, Albiero R, Ferenc M, Louvard Y. Percutaneous coronary intervention for coronary bifurcation disease: consensus from the first 10 years of the European Bifurcation Club meetings. EuroIntervention. 2014;10:545-60.
14. Verheye S, Ormiston JA, Stewart J, Webster M, Sanidas E, Costa R, Costa JR Jr, Chamie D, Abizaid AS, Pinto I, Morrison L, Toyloy S, Bhat V, Yan J, Abizaid A. The next-generation bioresorbable coronary scaffold system: from bench to first clinical evaluation: 6- and 12-month clinical and multimodality imaging results. JACC Cardiovasc Interv. 2014;7:89-99.
15. Turco MA, Ormiston JA, Popma JJ, Hall JJ, Mann T, Cannon LA, Webster MW, Mishkel GJ, O'Shaughnessy CD, McGarry TF, Mandinov L, Dawkins KD, Baim DS. Reduced risk of restenosis in small vessels and reduced risk of myocardial infarction in long lesions with the new thin-strut TAXUS Liberté stent: 1-year results from the TAXUS ATLAS program. JACC Cardiovasc Interv. 2008;1:699-709.
16. Ormiston JA, Dixon SR, Webster MW, Ruygrok PN, Stewart JT, Minchington I, West T. Stent longitudinal flexibility: a comparison of 13 stent designs before and after expansion. Catheter Cardiovasc Interv. 2000;50:120-4.
17. Serruys PW, Ormiston JA, Onuma Y, Regar E, Gonzalo N, Garcia-Garcia HM, Nieman K, Bruining N, Dorange C, Miquel-Hébert K, Veldhof S, Webster M, Thuesen L, Dudek D. A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods. Lancet. 2009;373:897-910.
18. Okamura T, Onuma Y, Garcia-Garcia HM, Regar E, Wykrzykowska JJ, Koolen J, Thuesen L, Windecker S, Whitbourn R, McClean DR, Ormiston JA, Serruys PW; ABSORB Cohort B Investigators. 3-Dimensional optical coherence tomographic assessment of jailed side branches by bioresorbable scaffolds: a proposal for classification. JACC Cardiovasc Interv. 2010;3:836-44.